Tetanus
Introduction
- 1 million cases per year worldwide; 20-30% mortality
- Elderly patients often have waning immunity and lack of boosters
- Diabetics and IVDU are at increased risk
- Puncture wounds account for 50% of cases in developed countries
Pathophysiology
- Acute, often fatal disease due to C. tetani anaerobic gram-positive rod
- Spores are ubiquitous in soil and animal faeces
- Usually introduced to wounds or injection sites as spore-forming non-invasive state but can germinate into toxin-producing vegetative form if oxygen tension drops i.e. crushed tissue, devitalised tissue, foreign body or infected wound
- Two exotoxins: tetanolysin (promotes replication) and tetanospasmin (all clinical sequelae)
- Tetanospasmin reaches nervous system via bloodstream to peripheral nerves and then retrograde neuronal transport
- Bloodborne tetanospasmin doesn’t cross BBB but retrograde neuronal transport allows it to reach CNS
- Tetanospasmin acts at motor end plates of skeletal muscle, spinal cord, brain and SNS
- Prevents release of inhibitory neurotransmitters glycine and GABA from presynaptic terminals leading to sympathetic overactivity, tetany and spasm
- No person-to-person transmission is possible
Clinical features
- Generalised muscular rigidity, violent muscular contractions and autonomic instability
- No wound is found in 10% of cases
- Can also develop from surgical procedures, otitis media, IVDU or umbilical stump infection in neonates
- Incubation period 24 hours to 1 month
- The shorter the incubation, the more severe the disease
- Generalised, cephalic and local variants
Clinical features
- Generalised tetanus
- 80% of cases
- Pain and stiffness in masster (lockjaw)
- The shorter the axons, the earlier the muscle is affected (hence face)
- Trismus leads to risus sardonicus
- Dysphagia, opisthotonos flexing of arms, clenching of fists, extension of lower extremities
- Mental status is normal
- Laryngospasm and respiratory muscle spasm can be life threatening
Hypersympathetic state occurs during second week and can be life-threatening - Spasms can last 3-4 weeks and recovery can take months with axonal regrowth
- Complications include rhabdo and long-bone fracture, PE, pneumonia and sepsis (prolonged hospitalisation)
Clinical features
- Neonatal tetanus
- Form of generalised tetanus in infants born to inadequately immunised mothers after unsterile treatment of umbilical stump
- Weak, irritable, weak suck and deterioration in 2nd week of life
- Cephalic tetanus
- Follows injuries to head or otitis media with CN dysfunction (mostly CN VII)
- Poor prognosis
- Local tetanus
- Focal spasticity/hypertonia near wound
- Resolves over weeks to months
- Can progress to generalised form
Diagnosis
- Clinical diagnosis
- No lab diagnosis
- C. tetani can be cultured from wounds without tetanus disease
- DDx
- Strychnine poisoning
- Dystonic reaction
- Hypocalcaemia tetany
- Neuroleptic malignant syndrome
- Serotonin syndrome
- Stiff man syndrome
- Peritonsillar abscess
- Peritonitis
- Meningeal irritation
- Rabies
- TMJ disease
Treatment
- Admit to ICU
- Respiratory compromise requires paralysis and RSI
- Minimise environmental stimuli to limit reflex convulsive spasms
- Tetanus IG
- Neutralises circulating tetanospasmin and toxin in wound but NOT toxin fixed in nervous system already
- Thus reduces mortality without improving symptoms
- 3000-6000IU IM once only (half-life 28 days)
- Wound management (debridement)
- Metronidazole 500mg IV BD
- IV midazolam for muscle relaxation (often large doses)
Treatment
- Autonomic dysfunction
- Magnesium sulphate
- Labetalol
- Morphine
- Clonidine
- Active immunisation
- Disease does not confer immunity
- ADT if over 10yo or DTPa if under 7
Prevention
- Only 60% of patients receive appropriate tetanus wound prophylaxis
- Everyone needs primary series of 3 vaccinations plus 2 boosters; after that do NOT need 10 yearly boosters
Tetanus-prone wounds
- Compound fractures
- Deep penetrating wounds
- Wounds containing foreign bodies
- Wounds with pyogenic infection
- Wounds with extensive tissue damage
- Contaminated wounds
- Reimplantation of avulsed tooth
Prevention
Hx | Time since last dose | Type of wound | Vaccination | TIG |
>=3 doses | <5 years | Any wound | No | No |
5-10 years | Clean minor | No | No | |
5-10 years | Any other wound | Yes | No | |
>10 years | Any wound | Yes | No | |
<3 doses or unsure | >10 years | Clean minor | Yes | No |
>10 years | Any other wound | Yes | Yes |
Last Updated on October 2, 2020 by Andrew Crofton
Andrew Crofton
0
Tags :